Tested Applications
| Positive IP detected in | mouse stomach tissue |
| Positive IHC detected in | human pancreas cancer tissue, human stomach tissue, human ovary tumor tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Immunoprecipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
| Immunohistochemistry (IHC) | IHC : 1:500-1:2000 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
66167-1-Ig targets Claudin 18 in WB, IHC, IF, IP, ELISA applications and shows reactivity with human, mouse samples.
| Tested Reactivity | human, mouse |
| Cited Reactivity | human, mouse |
| Host / Isotype | Mouse / IgG2a |
| Class | Monoclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag15517 Product name: Recombinant human CLDN18 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 185-261 aa of BC146668 Sequence: TLIGGVMMCIACRGLAPEETNYKAVSYHASGHSVAYKPGGFKASTGFGSNTKNKKIYDGGARTEDEVQSYPSKHDYV Predict reactive species |
| Full Name | claudin 18 |
| Calculated Molecular Weight | 261 aa, 28 kDa |
| Observed Molecular Weight | 29 kDa |
| GenBank Accession Number | BC146668 |
| Gene Symbol | CLDN18 |
| Gene ID (NCBI) | 51208 |
| RRID | AB_2881563 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Protein A purification |
| UNIPROT ID | P56856 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
Claudin 18 (CLDN18) belongs to the large claudin family of proteins, which are tetraspan transmembrane proteins of tight junctions (PMID: 11585919; 18036336). Claudins exhibit specific patterns of expression in different tissues (PMID: 15447685). CLDN18 is specifically expressed in the stomach and lung. CLDN18 has two alternatively spliced variants, CLDN18.1 and CLDN18.2. CLDN18.2 is a highly selective gastric lineage marker that determines the gastric phenotype in a neoplastic condition, whereas CLDN18.1 is lung specific (PMID: 11585919; 21832145). Altered CLDN18 expression has been reported in various human malignancies, including gastric cancer, lung adenocarcinoma, and pancreatic neoplasm (PMID: 17459057; 22076167; 21832145). This antibody can recognize both CLDN18.1 and CLDN18.2.
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for Claudin 18 antibody 66167-1-Ig | Download protocol |
| IP protocol for Claudin 18 antibody 66167-1-Ig | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
Claudin 18 Monoclonal antibody (Cat# 66167-1-Ig) — Citation Summary
This mouse monoclonal antibody (RRID: AB_2881563) has 9 total citations across journals including Mater Today Bio, Pharmaceuticals (Basel), Journal of Gastroenterology, Mucosal Immunology, Cancers (Basel), Histopathology, American Journal of Cancer Research, bioRxiv, and World Journal of Gastrointestinal Pathophysiology. Cited applications include WB, IHC, and IF in human and mouse samples. Research fields cover gastric cancer diagnosis/therapy, pancreatic ductal adenocarcinoma, colorectal cancer, cervical adenocarcinoma, asthma/epithelial barrier, cigarette-smoke-induced lung injury, and stomach tissue imaging by mass spectrometry.
| Species | Application | Title |
|---|---|---|
Mater Today Bio Ferritin-nanocaged aggregation-induced emission nanoaggregates for integrated sensitive detection and treatment of gastric cancer. | ||
Pharmaceuticals (Basel) Scutellarein from Erigeron breviscapus Inhibits Apoptosis-Mediated Epithelial Barrier Disruption and Alleviates Cigarette Smoke-Induced Lung Injury. | ||
J Gastroenterol Chemotherapy-induced cell cycle arrest is associated with increased claudin-18 isoform 2 expression and enhanced zolbetuximab-mediated cytotoxicity in gastric cancer. | ||
Mucosal Immunol Airway epithelium IgE-FcεRI Cross-Link Induces Epithelial Barrier Disruption in Severe T2-high Asthma | ||
Histopathology Claudin-18 expression in gastric type adenocarcinoma and HPV-associated adenocarcinoma of the uterine cervix. |

























